Esophageal and Esophagogastric Junction Cancer Treatment Regimens
Find the latest cancer treatment regimens for esophageal and esophagogastric junction cancers, including drugs such as ECF, cisplatin, and 5-FU.
Esophageal Cancer
Progression-Free Rate With Maintenance Therapy in Some Esophageal or Gastric Cancers May Be Associated With PD-L1 Level
In this interim analysis, PFS rates were compared in PD-L1–defined biomarker subsets of patients receiving maintenance durvalumab or capecitabine.
No Local Control or OS Benefit Seen With RT Dose Escalation in Inoperable Esophageal Cancer
In this study, patients were randomly assigned to receive standard-dose RT or standard-dose RT plus an integrated RT boost to the primary tumor.
Study Shows Association Between Low-Dose Aspirin Use and Risk for Gastric and Esophageal Cancers
Researchers present study findings that demonstrate the association between low-dose aspirin and risk for gastric or esophageal cancer at ESMO Congress 2019.
Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival
[Cancer Management and Research] Radiation dose, fractionation strategies, and predictive factors of response to therapy in patients with esophageal carcinoma are reviewed to determine if more intense local therapy would lead to better outcomes and for which patients.
Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
[Journal of Thoracic Disease] A randomized study investigated whether an mERAS protocol could result in improved recovery of aged patients with esophageal cancer undergoing esophagectomy.
Better Postoperative Outcomes With RAMIE for Esophageal Cancer
Research presented at the 2018 Gastrointestinal Cancers Symposium described benefits seen with RAMIE vs chemotherapy or chemoradiotherapy plus OTE for esophageal cancer.
Oral Microbiome Composition Linked to Esophageal Cancer Risk
Periodontal pathogen Tannerella forsythia linked to increased risk of esophageal adenocarcinoma
Breath Test Might Assist Detection of Stomach and Esophageal Cancers
Research presented at the 2017 European Cancer Congress describes the potential of a noninvasive diagnostic test for esophageal and gastric cancers that measures chemicals in the breath.
Cancer Stem Cell Research Suggests a New Approach to Treatment Resistance in Esophageal Cancer
Researchers reveal that miR-17 appears to be important in driving esophageal tumor resistance to radiotherapy.
